⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

January 1, 2021Neuro-Oncology AdvancesOpen Access

Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter phase II study

Shinji Kawabata Minoru Suzuki Katsumi Hirose Hiroki Tanaka Takahiro Katō Hiromi Goto Yoshitaka Narita Shin‐Ichi Miyatake

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

AB-BNCT demonstrated acceptable safety and prolonged survival for recurrent MG. AB-BNCT may increase the risk of brain edema due to re-irradiation for recurrent MG; however, this appears to be controlled well with bevacizumab.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kawabata et al. (2021) studied this question.

synapsesocial.com/papers/69db1834498b35d3e6a3c397 https://doi.org/10.1093/noajnl/vdab067

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Efficacy of Fractionated Stereotactic Reirradiation in Recurrent Gliomas: Long-Term Results in 172 Patients Treated in a Single InstitutionCohort Study · 2005 · 325 citations
2NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modalityRisk Assessment · 2012 · 860 citations
3Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working GroupClinical Trial · 2010 · 3,841 citations
4Prognostic Factors for Survival in Adult Patients With Recurrent Glioma Enrolled Onto the New Approaches to Brain Tumor Therapy CNS Consortium Phase I and II Clinical TrialsPrognostic Study · 2007 · 205 citations
5Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancerRetrospective Study · 2013 · 197 citations
6An investigation of boron neutron capture therapy for recurrent glioblastoma multiformeOriginal Research · 2007 · 46 citations
7Brain Tumor Registry of Japan (2005-2008)Registry Study · 2017 · 219 citations
8Phase II Trial of Tipifarnib in Patients With Recurrent Malignant Glioma Either Receiving or Not Receiving Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consortium StudyEarly-Phase Clinical Trial · 2006 · 154 citations
9Performance of intraoperative AI-assisted Label-Free Stimulated Raman Histology in Recurrent Brain TumorsNeuro-Oncology Advances · 2026
10Differentiating True Progression from Pseudoprogression in Glioblastomas: Dynamic Contrast Enhanced-MRI Habitat Analysis with Parsimonious Pharmacokinetic ModelNeuro-Oncology Advances · 2026

More from Neuro-Oncology Advances

More from Kyoto University

More from National Cancer Center Hospital East

More from Osaka University of Pharmaceutical Sciences

More from Southern Tohoku General Hospital